Tripp, Inc. – Trademark Portfolio
Entity Type: 03
Tripp, Inc. owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as TRIPP, MOOD ON DEMAND, and MINDFUL METAVERSE. Of these, 3 are registered. The portfolio spans 4 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 44 (Medical Services). Headquartered in Los Angeles, CA.
5877 Obama Blvd.
Los Angeles, CA 90016
Showing of trademarks Trademarks
Trademark Classifications
Tripp, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Tripp, Inc. have?
Tripp, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned.
What trademark classes does Tripp, Inc. file in?
Tripp, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Tripp, Inc.'s most well-known trademarks?
Tripp, Inc.'s registered trademark portfolio includes well-known marks such as TRIPP, MOOD ON DEMAND, and MINDFUL METAVERSE. These are among 3 currently registered trademarks in the portfolio.
What is Tripp, Inc.'s trademark registration success rate?
Tripp, Inc. has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.